Immunotherapy after progression to double immunotherapy: pembrolizumab and lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition.
Saved in:
| Title: | Immunotherapy after progression to double immunotherapy: pembrolizumab and lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition. |
|---|---|
| Authors: | Lyrarakis G; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece., Liontos M; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Anastasopoulou A; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece., Bouros S; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece., Gkoufa A; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece., Diamantopoulos P; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece., Gogas H; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece., Ziogas DC; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Oct 07; Vol. 14, pp. 1420879. Date of Electronic Publication: 2024 Oct 07 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39435288 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunotherapy after progression to double immunotherapy: pembrolizumab and lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lyrarakis+G%22">Lyrarakis G</searchLink>; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Liontos+M%22">Liontos M</searchLink>; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Anastasopoulou+A%22">Anastasopoulou A</searchLink>; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Bouros+S%22">Bouros S</searchLink>; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Gkoufa+A%22">Gkoufa A</searchLink>; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Diamantopoulos+P%22">Diamantopoulos P</searchLink>; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Gogas+H%22">Gogas H</searchLink>; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Ziogas+DC%22">Ziogas DC</searchLink>; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Oct 07; Vol. 14, pp. 1420879. <i>Date of Electronic Publication: </i>2024 Oct 07 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39435288 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2024.1420879 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1420879 Titles: – TitleFull: Immunotherapy after progression to double immunotherapy: pembrolizumab and lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lyrarakis G – PersonEntity: Name: NameFull: Liontos M – PersonEntity: Name: NameFull: Anastasopoulou A – PersonEntity: Name: NameFull: Bouros S – PersonEntity: Name: NameFull: Gkoufa A – PersonEntity: Name: NameFull: Diamantopoulos P – PersonEntity: Name: NameFull: Gogas H – PersonEntity: Name: NameFull: Ziogas DC IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 10 Text: 2024 Oct 07 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
